A meta-analysis of randomized controlled trials comparing breast-conserving surgery and mastectomy in terms of patient survival rate and quality of life in breast cancer
- PMID: 38753325
- PMCID: PMC11141600
- DOI: 10.1093/intqhc/mzae043
A meta-analysis of randomized controlled trials comparing breast-conserving surgery and mastectomy in terms of patient survival rate and quality of life in breast cancer
Abstract
The study aimed to assess the effects of breast-conserving surgery (BCS) versus mastectomy on survival and quality of life in Stages I, II, and III breast cancer, providing solid evidence for clinical decisions. We conducted a meta-analysis of randomized controlled trials on breast cancer treatments, searching databases such as PubMed and the Cochrane Library to compare BCS, and mastectomy's effects on survival and quality of life. A combined total of 16 734 patients in the control group and 17 435 patients in the experimental group were included in this analysis. This meta-analysis used RevMan 5.3 (Cochrane Collaboration, Copenhagen, Denmark) software for analysis. Our meta-analysis of 34 169 patients from 11 studies showed that BCS significantly reduced the overall recurrence rate at a median follow-up of 29 months, with a mean difference of 1.27 and a 95% confidence interval of 1.19-1.36, strongly supporting its effectiveness (P < .00001). Furthermore, our analysis found no significant increase in 5-year local recurrence rates for BCS versus mastectomy, indicating its long-term effectiveness with a mean difference of 1.13 (95% confidence interval: [1.03, 1.24], P = .01). Additionally, there was a notable decrease in tissue ischaemic necrosis among patients who had received BCS, with a mean difference of 0.37 (95% confidence interval: [0.33, 0.42], P < .00001), underscoring its benefits and long-term viability. BCS resulted in fewer cases of tissue ischaemic necrosis and higher body image scores compared with mastectomy, suggesting that it is a preferable option for better cosmetic outcomes and potentially favourable effects on prognosis and quality of life.
Keywords: breast neoplasms; breast-conserving; mastectomy; quality of life; survival rate.
© The Author(s) 2024. Published by Oxford University Press on behalf of International Society for Quality in Health Care.
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Breast-conserving surgery in early-stage breast cancer (indications, local recurrences, survival, cosmetic results).Folia Med (Plovdiv). 2006;48(1):23-30. Folia Med (Plovdiv). 2006. PMID: 16918051
-
Breast Conserving Surgery for BRCA Mutation Carriers-A Systematic Review.Clin Breast Cancer. 2020 Jun;20(3):e244-e250. doi: 10.1016/j.clbc.2019.07.014. Epub 2019 Aug 22. Clin Breast Cancer. 2020. PMID: 32144082
-
Oncoplastic breast conserving surgery versus standard breast conserving surgery for early and locally advanced breast cancer: a retrospective analysis from Sri Lanka.BMC Surg. 2023 Sep 11;23(1):273. doi: 10.1186/s12893-023-02182-5. BMC Surg. 2023. PMID: 37697322 Free PMC article.
-
Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy.Breast. 2015 Jun;24(3):175-81. doi: 10.1016/j.breast.2015.02.002. Epub 2015 Feb 23. Breast. 2015. PMID: 25728282 Review.
-
Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.Breast. 2022 Jun;63:29-36. doi: 10.1016/j.breast.2022.03.006. Epub 2022 Mar 12. Breast. 2022. PMID: 35299032 Free PMC article.
Cited by
-
Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease.Cancers (Basel). 2024 Jun 30;16(13):2421. doi: 10.3390/cancers16132421. Cancers (Basel). 2024. PMID: 39001483 Free PMC article.
-
Hyaluronic acid 0.2 % cream for preventing radiation dermatitis in breast cancer patients treated with postoperative radiotherapy: A randomized, double-blind, placebo-controlled study.Breast. 2025 Aug;82:104513. doi: 10.1016/j.breast.2025.104513. Epub 2025 Jun 12. Breast. 2025. PMID: 40540938 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical